TMDX
TransMedics Group·NASDAQ
--
--(--)
--
--(--)
5.71 / 10
Netural
Fund flow metrics score 8.1/10, revealing exceptionally strong fund flow dynamics. Beneficial overall, block, Small, Medium, Large, and Extra-large trends are challenged by problematic no significant trends signals, indicating highly favorable capital movement. Research analyst consensus shows predominantly positive analyst sentiment, demonstrating moderate confidence. Current ratings: Strong Buy(66.7%), Neutral(33.3%) across 3 coverage providers, supported by 3.33 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
67%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-08
InstitutionNeedham
Times predicted7
Historical Win Rate28.6%
Is money flowing into or out of TMDX?
- TMDX holds a Bearish analyst rating, with 67% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.71/10 (Netural).
